These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8950788)

  • 1. Functional expression of single chain glycoprotein Ib alpha on the surface of COS cells and BHK cells.
    Petersen EJ; Posthumus E; Sixma JJ
    Thromb Haemost; 1996 Nov; 76(5):768-73. PubMed ID: 8950788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the leucine-rich domain of platelet GPIbalpha in correct post-translational processing--the Nancy I Bernard-Soulier mutation expressed on CHO cells.
    Ulsemer P; Lanza F; Baas MJ; Schwartz A; Ravanat C; Briquel ME; Cranmer S; Jackson S; Cazenave JP; de la Salle C
    Thromb Haemost; 2000 Jul; 84(1):104-11. PubMed ID: 10928479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A template-assembled synthetic protein surface mimetic of the von Willebrand factor A1 domain inhibits botrocetin-induced platelet aggregation.
    Hauert J; Fernandez-Carneado J; Michielin O; Mathieu S; Grell D; Schapira M; Spertini O; Mutter M; Tuchscherer G; Kovacsovics T
    Chembiochem; 2004 Jun; 5(6):856-64. PubMed ID: 15174170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. von Willebrand factor without the A2 domain is resistant to proteolysis.
    Lankhof H; Damas C; Schiphorst ME; Ijsseldijk MJ; Bracke M; Furlan M; Tsai HM; de Groot PG; Sixma JJ; Vink T
    Thromb Haemost; 1997 May; 77(5):1008-13. PubMed ID: 9184419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential aspects of the glycoprotein Ib-von Willebrand factor axis in human and pig species.
    Zurbano MJ; Escolar G; Heras M; Ordinas A; Castillo R
    Haematologica; 2000 May; 85(5):514-9. PubMed ID: 10800169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of the structure and function of the von Willebrand factor A1 domain using targeted deletions and alanine-scanning mutagenesis.
    Kroner PA; Frey AB
    Biochemistry; 1996 Oct; 35(41):13460-8. PubMed ID: 8873615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine structural and functional consequences of deglycosylation of the platelet adhesion receptor GPIb-IX (CD 42b).
    Moshfegh K; Lengweiler S; Häner M; Aebi U; Steiner B; Beer JH
    Biochem Biophys Res Commun; 1998 Aug; 249(3):903-9. PubMed ID: 9731234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and characterization of jararaca GPIb-BP, a snake venom antagonist specific to platelet glycoprotein Ib.
    Fujimura Y; Ikeda Y; Miura S; Yoshida E; Shima H; Nishida S; Suzuki M; Titani K; Taniuchi Y; Kawasaki T
    Thromb Haemost; 1995 Aug; 74(2):743-50. PubMed ID: 8585016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex.
    Graham SS; Gonchoroff NJ; Miller JL
    Am J Clin Pathol; 2001 Jan; 115(1):144-7. PubMed ID: 11190800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition assay for the binding of biotinylated von Willebrand factor to platelet-bound microtiter wells in the presence of ristocetin or botrocetin.
    Miura S; Nishida S; Makita K; Sakurai Y; Shimoyama T; Sugimoto M; Yoshioka A; Ishii K; Kito M; Kobayashi T; Fujimura Y
    Anal Biochem; 1996 May; 236(2):215-20. PubMed ID: 8660497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N1421K mutation in the glycoprotein Ib binding domain impairs ristocetin- and botrocetin-mediated binding of von Willebrand factor to platelets.
    Lanke E; Kristoffersson AC; Isaksson C; Holmberg L; Lethagen S
    Eur J Haematol; 2008 Nov; 81(5):384-90. PubMed ID: 18637125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel monoclonal antibody against the extracellular domain of GPIbbeta modulates vWF mediated platelet adhesion.
    Perrault C; Moog S; Rubinstein E; Santer M; Baas MJ; de la Salle C; Ravanat C; Dambach J; Freund M; Santoso S; Cazenave JP; Lanza F
    Thromb Haemost; 2001 Nov; 86(5):1238-48. PubMed ID: 11816713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient expression of recombinant glycoprotein Ib alpha polypeptides in COS cells that inhibit von Willebrand factor binding to the platelet glycoprotein Ib/IX complex.
    Petersen E; Handin RI
    Thromb Haemost; 1992 Aug; 68(2):203-7. PubMed ID: 1412167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of von Willebrand factor binding to a recombinant fragment of glycoprotein Ibalpha in an enzyme-linked immunosorbent assay-based method: performances in patients with type 2B von Willebrand disease.
    Caron C; Hilbert L; Vanhoorelbeke K; Deckmyn H; Goudemand J; Mazurier C
    Br J Haematol; 2006 Jun; 133(6):655-63. PubMed ID: 16704443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type 2M vWD resulting from a lysine deletion within a four lysine residue repeat in the A1 loop of von Willebrand factor.
    Hilbert L; Jenkins PV; Gaucher C; Meriane E; Collins PW; Pasi KJ; Mazurier C
    Thromb Haemost; 2000 Aug; 84(2):188-94. PubMed ID: 10959688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoplasmic truncation of glycoprotein Ib alpha weakens its interaction with von Willebrand factor and impairs cell adhesion.
    Schade AJ; Arya M; Gao S; Diz-Küçükkaya R; Anvari B; McIntire LV; López JA; Dong JF
    Biochemistry; 2003 Feb; 42(7):2245-51. PubMed ID: 12590614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. von Willebrand factor but not alpha-thrombin binding to platelet glycoprotein Ibalpha is influenced by the HPA-2 polymorphism.
    Ulrichts H; Vanhoorelbeke K; Cauwenberghs S; Vauterin S; Kroll H; Santoso S; Deckmyn H
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1302-7. PubMed ID: 12775575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surface-secreted von Willebrand factor mediates aggregation of ADP-activated platelets at moderate shear stress: facilitated by GPIb but controlled by GPIIb-IIIa.
    Frojmovic MM; Kasirer-Friede A; Goldsmith HL; Brown EA
    Thromb Haemost; 1997 Mar; 77(3):568-76. PubMed ID: 9066012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mucin-like macroglycopeptide region of glycoprotein Ibalpha is required for cell adhesion to immobilized von Willebrand factor (VWF) under flow but not for static VWF binding.
    Li CQ; Dong JF; López JA
    Thromb Haemost; 2002 Oct; 88(4):673-7. PubMed ID: 12362242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.